EUVIMEDEUVIMED entdecken
Open Access

VITAFOOT: A Double-Blind, Randomized Controlled Pilot Trial of Combined Vitamin C, Vitamin A, and Zinc Supplementation in People With Nonhealing Diabetes-Related Foot Ulcers

Joanne Nixon, Jonathan Hiew iD, Melissa Ting, Lauren T Tyack iD, Simon Edeghere, Tsepo Llewellyn, Lloyd Nash, Alana Di Giacomo, Cathy Latino iD, J Carsten Ritter iD, Damon Bell iD, Laurens Manning iD und 1 weitere

Diabetes Obesity and Cardiometabolic CARE · 01.07.2026 · 1 (4) · 609-617

DOI: 10.2337/doc26-0017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Obesity and Cardiometabolic CARE, online erschienen am 14.07.2026. Verfasst von Joanne Nixon und 12 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Department, Fiona Stanley and Fremantle Hospital Group, Murdoch, Perth, Western Australia, Australia. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Future Fund, Western Australian Future Health Research and Innovation Fund, Western Australia Country Health Service (WACHS) Trial Centre.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Micronutrient deficiencies are common in patients with diabetes-related foot ulcers (DFUs); however, effects of micronutrient supplementation on DFU healing are unclear. We evaluated the effect of combined vitamin C (VitC), vitamin A (VitA), and zinc supplementation on wound healing in patients with nonhealing DFUs. RESEARCH DESIGN AND METHODS Participants in the VITAFOOT study, a double-blind, randomized controlled pilot trial, were assigned to receive 28 days of combination supplement containing VitC (1,000 mg), VitA (750 μg/2,500 IU), and zinc picolinate (25 mg) daily or identical placebo. The primary outcome was percentage change in DFU area from baseline to 12 weeks. Post hoc exploratory outcomes included complete healing at 4 and 12 weeks. RESULTS Ninety-nine participants were randomized to either the placebo (n = 50) or the intervention (n = 49) group. Baseline deficiencies in VitC, VitA, and zinc were observed in 49 (49.5%), 1 (1%), and 11 (11.1%) participants, respectively. At 12 weeks, there was a median (interquartile range) 65% (10–100%) reduction in DFU area in the intervention group and 75% (43–100%) reduction in DFU area in the placebo group (P = 0.42). At 4 weeks, 7 of 49 DFUs (14.3%) healed in the intervention group compared with 1 of 50 (2%) in the placebo group (P = 0.02). At 12 weeks, 13 of 49 wounds (26.5%) were healed in the intervention group, as were 14 of 50 (28%) in the placebo group (P = 0.87). CONCLUSIONS Despite high baseline rates of VitC deficiency, micronutrient supplementation for 28 days did not improve percentage change in DFU area at 12 weeks. A higher proportion of patients had complete DFU healing at 4 weeks in the intervention group, but there was no difference at 12 weeks compared with standard care.

Autor:innen und Institutionen

  • Infectious Diseases Department, Fiona Stanley and Fremantle Hospital Group, Murdoch, Perth, Western Australia, Australia.
  • Centre of Excellence Multidisciplinary Diabetes Foot Ulcer Unit, Fiona Stanley and Fremantle Hospital Group, Murdoch, Perth, Western Australia, Australia.
  • Podiatry Department, Fiona Stanley and Fremantle Hospital Group, Murdoch, Perth, Western Australia, Australia.
  • Endocrinology Department, Fiona Stanley and Fremantle Hospital Group, Murdoch, Perth, Western Australia, Australia.
  • Podiatry Department, Albany Health Campus, Albany, Western Australia, Australia.
  • General Medicine Department, Albany Health Campus, Albany, Western Australia, Australia.

ORCID-Profile: Jonathan Hiew, Lauren T Tyack, Cathy Latino, J Carsten Ritter, Damon Bell, Laurens Manning, Emma J Hamilton

Förderung

  • Medical Research Future Fund
  • Western Australian Future Health Research and Innovation Fund
  • Western Australia Country Health Service (WACHS) Trial Centre
  • MRFF Rural, Regional and Remote Clinical Trial Enabling Infrastructure Fund

Zitieren

APA

Nixon, J., Hiew, J., Ting, M., Tyack, L. T., Edeghere, S., Llewellyn, T., Nash, L., Di Giacomo, A., Latino, C., Ritter, J. C., Bell, D., Manning, L., & Hamilton, E. J. (2026). VITAFOOT: A Double-Blind, Randomized Controlled Pilot Trial of Combined Vitamin C, Vitamin A, and Zinc Supplementation in People With Nonhealing Diabetes-Related Foot Ulcers. Diabetes Obesity and Cardiometabolic CARE, 1(4), 609-617. https://doi.org/10.2337/doc26-0017

Vancouver

Nixon J, Hiew J, Ting M, Tyack LT, Edeghere S, Llewellyn T, et al. VITAFOOT: A Double-Blind, Randomized Controlled Pilot Trial of Combined Vitamin C, Vitamin A, and Zinc Supplementation in People With Nonhealing Diabetes-Related Foot Ulcers. Diabetes Obesity and Cardiometabolic CARE. 2026;1(4):609-617. doi:10.2337/doc26-0017

BibTeX
@article{Nixon2026,
  author = {Nixon, Joanne and Hiew, Jonathan and Ting, Melissa and Tyack, Lauren T and Edeghere, Simon and Llewellyn, Tsepo and Nash, Lloyd and Di Giacomo, Alana and Latino, Cathy and Ritter, J Carsten and Bell, Damon and Manning, Laurens and Hamilton, Emma J},
  title = {VITAFOOT: A Double-Blind, Randomized Controlled Pilot Trial of Combined Vitamin C, Vitamin A, and Zinc Supplementation in People With Nonhealing Diabetes-Related Foot Ulcers},
  journal = {Diabetes Obesity and Cardiometabolic CARE},
  year = {2026},
  volume = {1},
  number = {4},
  pages = {609--617},
  doi = {10.2337/doc26-0017}
}
Kostenlos starten →